We developed an approach and bioinformatics software pipeline to establish a metric, i.e., the accessibility score, for inferring TF binding from cfDNA in the blood, with relevance for clinical diagnostics and noninvasive tumor classification. The gene discussed is TF; the disease is neoplasm.